Hydrofarm Q3 Sales Halve to $14.5M as Term Loan Wiped Out
HYFM sits 37% above its 52-week low of $0.5 on light trading volume (0.2× avg).
Summary
Q3 net sales fell 50.7% to $14.5 million from $29.4 million, driven by discontinued distributed brands, Canadian divestitures and constrained working capital ahead of the recapitalization. The margin picture improved sharply: adjusted gross margin rose to 23.6% from 18.8% and adjusted SG&A dropped 54.1%, cutting the net loss to $7.8 million from $16.4 million and adjusted EBITDA to $(1.1) million from $(4.4) million. The company also confirmed the October recapitalization eliminated the $109 million term loan in exchange for $27.5 million of Series 1 preferred and 27.5 million warrants at $0.78, alongside the $8.3 million equity raise, leaving roughly 41.8 million common shares outstanding. Cash burn remains the issue: free cash flow was $(7.5) million for the quarter, including a $4.4 million interest payment and $2.8 million of debt and restructuring costs, against $3.9 million of cash at quarter end. Management says it expects to reach positive adjusted EBITDA within the next year, which is the number to hold them to.
At the time of this announcement, HYFM was trading at $0.68 on NASDAQ in the Trade & Services sector, with a market capitalization of approximately $9.1M. The 52-week trading range was $0.50 to $3.20. This news item was assessed with neutral market sentiment and an importance score of 7 out of 10. Source: GlobeNewswire.